BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

South Korea

SCN9A Antisense Pain Killer OLP-1002 Moves into Phase 2a Stage

In the Phase 2a trial of a two stage adaptive design in OA patients with pain, OLP-1002 shall be evaluated for analgesic efficacy, safety and therapeutic d...

October 26, 2021 | News

Korean Ginseng Research Institute Announces potential COVID-19 Vaccine Adjuvant Effect of Red Ginseng

The results of the study summarized this time showed that red ginseng increased the effectiveness of the vaccine, so that when red ginseng was taken togeth...

October 22, 2021 | News

South Korea Advances Digital Radiography System

South Korean artificial intelligence (AI) developer, VUNO Inc., announced today that the company closed a deal with global medical device manufacturer, Sam...

October 06, 2021 | News

GenScript establishes Korean legal entity and accelerates sales activities

GenScript Biotech Korea Ltd. has built a nest at IKP (Invest Korea Plaza) in Heolleung-ro, Seocho-gu, Seoul. The main purpose of the establishment of ...

October 05, 2021 | News

South Korea Advances Treatment of Polymyositis

Immunoforge (Co-CEOs Sung-min Ahn, Kiho Chang), a company specializing in developing new drugs for rare musculoskeletal diseases, has reported that th...

September 28, 2021 | News

Illumina reaffirms commitment to the National Project of Bio Big Data in Korea

The multi-ministerial project is overseen by the Ministry of Health and Welfare, Ministry of Trade and Industry, Ministry of Science and ICT, and Korea Dis...

September 20, 2021 | News

Approval to Market Sofwave(TM) in South Korea

Sofwave Medical LTD, today announced it has received approval from the Korean Ministry of Foods and Drug Safety (MFDS) to market Sofwave™ its pr...

August 31, 2021 | News

ExoCoBio to Build the World’s First Clinical Grade Exosome GMP Manufacturing Facility

ExoCoBio will invest approximately US $20M to build the EGMP facility whose project actually started in 2019, and after two years of intensive ...

August 26, 2021 | News

MFDS Greenlights VUNO Med®-DeepCARS™, AI Medical Device for Cardiac Arrest Prediction

VUNO Med®–DeepCARS™ is a breakthrough AI-driven medical device that analyzes the potential risk of cardiac arrest using four primar...

August 24, 2021 | News

HDT Bio ,Korea’s Quratis to Co-Develop COVID-19 Vaccine in Asia

HDT Bio Corp., a developer of immunotherapies for oncology and infectious diseases, announced today an agreement with Korean biotech Quratis Inc. to co-dev...

August 18, 2021 | News

Fujifilm Introduces its AI-powered Product for Chest X-ray in Japan, in Collaboration with Lunit

Fujifilm Corporation, a global medical imaging device provider, today announced its AI-powered product for analyzing chest X-ray 'CXR-AID' will be commerci...

August 13, 2021 | News

South Korea to Expand patient access to incision-free Focused Ultrasound treatment

Insightec®, a global healthcare company focused on creating the next generation of patient care, announced Seoul National University Ho...

August 09, 2021 | News

Yuyu Pharma Signs Exclusive Distribution Agreement with Novartis Korea

Yuyu Pharma, a pharmaceutical company based in Korea, and Novartis Korea announced today that the companies have entered into an agreement in which Yuyu wi...

August 04, 2021 | News

LISCure, the first Korean biotech company receiving equity investment from Mayo Clinic

LISCure Biosciences, Inc. ("LISCure") has entered into a know-how license and development collaboration agreement, and stock purchase agreement with Mayo C...

July 26, 2021 | News

Stay Connected